Femasys Inc 's (FEMY) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Femasys Inc   (NASDAQ: FEMY)
 



  Femasys Inc Outlook

On March 28 2024 the Femasys Inc provided following guidance

Femasys Inc. has recently announced its financial results for the year ended December 31, 2023, along with some key updates on its corporate activities. The company's latest achievement includes receiving FDA clearance for FemaSeed, a significant milestone that has allowed Femasys to secure capital for supporting its commercial initiatives. With this funding in place, the company anticipates that its cash reserves will be sufficient to sustain its operations well into the second half of 2025. This development marks a positive trajectory for Femasys as it continues to pursue its strategic objectives and advance its innovative healthcare solutions.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.